Can marine-derived fungus Neosartorya siamensis KUFA 0017 extract and its secondary metabolites enhance antitumor activity of doxorubicin? An in vitro survey unveils interactions against lung cancer cells

Doxorubicin (Dox) is one of the most successful anticancer drugs in use. However, chemoresistance is one of the main limitations that patients face. Therefore, development of new strategies to improve the efficacy of Dox is needed. Marine-derived fungi are especially promising sources of new antican...

ver descrição completa

Detalhes bibliográficos
Autor principal: Ramos, A.A. (author)
Outros Autores: Castro-Carvalho, B. (author), Prata-Sena, M. (author), Malhão, F. (author), Buttachon, S. (author), Dethoup, T. (author), Kijjoa, A. (author), Rocha, E. (author)
Formato: article
Idioma:eng
Publicado em: 2020
Assuntos:
Neosartorya siamensis
doxorubicin
drug combination
in vitro anticancer activity
marine-derived compounds
marine-derived fungal extract
non-small cell lung cancer
Texto completo:https://hdl.handle.net/10216/130488
País:Portugal
Oai:oai:repositorio-aberto.up.pt:10216/130488

Texto Completo

https://hdl.handle.net/10216/130488

Registos relacionados